NCT06554587View on ClinicalTrials.gov

Investigation of Three Biomarkers for the Detection of Prostate Cancer

RecruitingOBSERVATIONAL
Enrollment

137

Participants

Timeline

Start Date

January 7, 2025

Primary Completion Date

January 7, 2026

Study Completion Date

March 7, 2026

Conditions
Cancer of Prostate
Interventions
DIAGNOSTIC_TEST

Laboratory Biomarker Analysis: Enzyme-linked immunosorbent assay (ELISA)

Measurement of the plasma concentration of ST6GAL1, GCNT1 and GALNT7 biomarkers in patients suspected of having prostate cancer or on active surveillance

Trial Locations (1)

L7 8XP

RECRUITING

Royal Liverpool University Hospital, Liverpool

All Listed Sponsors
collaborator

GlycoscoreDx Ltd

UNKNOWN

lead

Medtechtomarket Consulting Ltd

INDUSTRY